ĀÜĄņĀŅĀ×

He has more than 25 years of experience in biotechnology and was involved in the development of many pioneering biotechnology products at Genentech (ActivaseĀ®, ProtropinĀ®, HerceptinĀ® and XolairĀ®) and managed a large part of the development effort as VP of Product Development. In 1996, he joined Aviron (now MedImmune Vaccines) as VP of Development to build the expertise needed to advance new vaccines from research through product development. He was project leader of the intranasal influenza vaccine (FluMistā„¢) during preclinical and clinical development. Dr. Patzer received his Ph.D. in Microbiology at the University of Virginia and was a Helen Hay Whitney Fellow at Stanford University.